Genentech, a member of the Roche Group

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. To revolutionise healthcare, Roche is investing heavily in R&D with CHF 11.7 billion in 2019. This is amongst the highest R&D spends in the world across all industries.
Genentech, a member of the Roche Group, discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. We are a leading biotech company, with ~40 approved medicines and a promising development pipeline.
Roche Pharma Partnering provides comprehensive business development and alliance management support for Roche and Genentech's R&D units and the broader pharmaceutical division. Alongside our broad internal pipeline, external innovation has always been a critical component of our R&D strategy. We believe that through the right partnerships, we collectively can change the way the industry thinks about developing medicines.
Ticker:
RHHBY
Exchange:
SIX SWISS EXCHANGE
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Multiple Products in Development
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Vice President, Head of Business Development for gRED, Pharma Partnering
Genentech, a member of the Roche Group